Accuracy of fasting glucose to diagnose diabetes in Brazilian subjects
Dear Sir, In a recently published article, the DECODE Study Group looked at the accuracy of fasting plasma glucose to define diabetes in a sample of more than 45 000 people from 20 European epidemiological studies [1] . They observed that among people with a diabetic 2-hour plasma glucose of 11.1 mmol or more during an oral glucose tolerance test (OGTT) more than 50 % had a fasting plasma glucose (FPG) less than 7.0 mmol/l (the revised FPG criteria of diabetes [2, 3] ) and in 31 % it was less than 6.1 mmol/l (the revised criteria of normal FPG). These data contrast with data from the United States and the Pacific Islands where a fasting blood glucose of 7.0 mmol/l was roughly equivalent, as a diagnostic cutpoint, to a 2-h plasma glucose of 11.1 mmol/l [2, 3] . These contrasting results fuel the controversy on whether or not the OGTT should be kept as a diagnostic tool of diabetes [2±4], and the DECODE Study Group report concludes that it is important to further analyse the impact of using only fasting plasma glucose for diagnosing diabetes in other populations [1] .
We have analysed a sample of 6 066 subjects without previously known diabetes who underwent a 75-g OGTT for diagnostic purposes at the H. Pardini Istitute of Clinical Pathology in the city of Belo Horizonte, state of Minas Geraes, Brazil. The subjects were referred by their doctors for the OGTT, either because they had a family history of Type II (non-insulindependent) diabetes mellitus, because of a clinical suspicion of diabetes, or as part of a health check-up. Women known to be pregnant were not included in the study. The average age of the participants was 41 ± 13 years (m ± SD) with a range of 25 to 86 years; 76 % (n = 4610) of the subjects were women and 24 % (n = 1456) were men. This sample of subjects is not population-based but medical-recruited. Thus, recruitment bias might have affected some of the results, especially the frequencies of diabetes and impaired glucose tolerance (IGT), which should not be taken as representative of those of the general population. Plasma glucose was measured by the glucose-oxydase method. A receiver operating characteristics (ROC) curve [5] was constructed to test the ability of fasting plasma glucose to discriminate non-diabetic and diabetic subjects defined by 2-h plasma glucose lower than, or equal or higher than 11.1 mmol/l, respectively (Fig. 1) . The ROC curve is a graphical plot of all the sensitivity/specificity pairs resulting from continuously varying the cutpoint value of fasting plasma glucose defining positivity (that is, diabetes) over the range of possible values.
A 2-h plasma glucose of 11.1 mmol/l or more was observed in 496 subjects. Of these, only 94 had a fasting plasma glucose of 7.8 mmol/l or more (1980/WHO diagnostic criteria of diabetes [6] ), only 180 of 7.0 mmol/l or more, and only 350 of 6.1 mmol/l or more. On the other hand, of the 5570 subjects with 2-h plasma glucose less than 11.1 mmol/l, only 6 had a fasting plasma glucose of 7.8 mmol/l or more, only 43 of 7.0 mmol/l or more and only 238 of 6.1 mmol/l or more. Thus, sensitivity and specificity of the diagnoses of diabetes were 19.0 % and 99.9 % at the fasting plasma glucose cut-point of 7.8 mmol/l, 36.3 % and 99.2 % at that of 7.0 mmol/l and 70.6 % and 95.7 % at that of 6.1 mmol/l, respectively. Our data are in fair agreement with the data from the DECODE report in that almost one in three people with diabetes according to the 2-h plasma glucose would be considered normal if tested only by a fasting plasma glucose. Our data also agree with the DECODE report that the range of the optimal fasting plasma glucose cut-point corresponding to a 2-h plasma glucose of 11.1 or more mmol/l is around 5.8±6.1 mmol/l. As seen in figure 1 , a further decrease in the fasting plasma glucose cut-point results in a trade-off between sensitivity and specificity. A third point of agreement is the poor ability of fasting plasma glucose to detect people with IGT diagnosed by the OGTT, in whom intervention aiming at the prevention of overt diabetes might be considered. Out of the 906 subjects with IGT in our sample, 79.5 % had a fasting plasma glucose less than 6.1 mmol/l and would be considered normal if only so tested. This issue is important, as IGT seems to also be a risk factor for cardiovascular disease whereas impaired fasting glucose (6.1 mmol/l K FPG < 7.0 mmol/l), the new category of mild hyperglycaemia based on fasting plasma glucose is not [7] .
In conclusion, in this sample of Brazilian subjects the fasting plasma glucose remains a poor discriminator of IGT and of diabetes defined as 2-h plasma glucose of 11.1 mmol/l or more. This suggests that the OGTT might still be useful for the detection of early stages or milder forms of hyperglycaemia or both. Caution should be adopted in using fasting plasma glucose to classify the glucose tolerance status of people participating in genetic studies of diabetes. About one third of the diabetic and more than two thirds of the glucose intolerant subjects of our sample had a fasting plasma glucose less than 6.1 mmol/l and would have been misclassified. Ideally, an OGTT should be required to label a subject as ªunaffectedº. This is particularly relevant for family members in the case of linkage and unaffected sib-pair analysis but might also be important for the control group of association studies.
Yours sincerely, V. C. Pardini, H. Pardini, G. Velho Fig. 1 . ROC curve showing sensitivity and specificity of various fasting plasma glucose cut-points (·) to discriminate diabetes defined by 2-h plasma glucose of 11.1 mmol/l or more. Sensitivity was defined as the true positive fraction (FPG-positive diabetic subjects / all diabetic subjects) and specificity as the true negative fraction (FPG-negative non-diabetic subjects / all non-diabetic subjects)
